| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 33 | 80 | -1.81 | 0.74 | BLENDED GS |
| May 2025 | 83 | 80 | -4.31 | 2.33 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 33 | 80 | -1.81 | 0.74 | BLENDED GS |
| May 2025 | 83 | 80 | -4.31 | 2.33 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 156 | 100 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 100 | 156 | 7871 | 379 | 382 | 87 | 87 |
| May 2025 | 99 | 155 | 7841 | 379 | 382 | 87 | 87 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 100 | 156 | 7871 | 379 | 382 | 87 | 87 |
| May 2025 | 99 | 155 | 7841 | 379 | 382 | 87 | 87 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 153 | 134 | 110 | 96 | 67 |
| No. Herds | 97 | 91 | 78 | 74 | 55 |
| No. without completed record | 1 | 1 | 1 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 153 | 134 | 110 | 96 | 67 |
| No. Herds | 97 | 91 | 78 | 74 | 55 |
| No. without completed record | 1 | 1 | 1 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 156 | 100 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 0 | 0 | 0 | 0 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 0 | 0 | 0 | 0 |
| GER | 0 | 0 | 0 | 0 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 0 | 0 |